良性甲状腺结节体积与直径的变化:一项10年随访研究
该回顾性队列研究纳入376例甲状腺功能正常患者的732个细胞学良性或超声低至中危结节,由同一超声医师在基线、第5年和第10年评估。体积标准较直径标准更常检出显著结节生长,年轻、结节数量多和结节体积小与生长相关,但恶性率低。
要点
- 体积标准检出的显著结节生长率高于直径标准(第10年44% vs 35%)。
- 年龄小于45岁、结节数量多和初始结节体积小与显著结节生长相关。
- 生长结节中甲状腺癌诊断率为0.5%(4个原发结节),活检恶性率为1.4%。
核心结论
- 在超声和/或细胞学良性甲状腺结节的长期随访中,显著结节生长并不罕见,但恶性罕见。
- 生长更可能发生于年轻患者、结节数量较多者和较小结节。
- 随访结节大小时,体积标准较直径标准产生更高的生长检出率。
研究设计与样本
- 回顾性队列研究,在安卡拉大学医学院内分泌与代谢科开展。
- 纳入376例甲状腺功能正常患者的732个结节,结节为细胞学良性和/或超声低至中危类别。
- 由同一经验丰富的超声医师在基线、第5年和第10年进行评估,随访10年。
- 采用广义线性混合效应模型分析影响结节生长的因素。
主要发现
- 第5年和第10年显著结节生长率:体积标准分别为27.7%(n=203)和44%(n=321),直径标准分别为19.1%(n=140)和35%(n=256),差异有统计学意义(McNemar检验,p<0.01)。
- 年龄小于45岁与显著结节生长相关:体积标准OR=1.704,CI=1.227-2.366,p=0.002;直径标准OR=1.913,CI=1.379-2.656,p<0.001。
- 结节数量较多与显著结节生长相关:体积标准OR=1.171,CI=1.061-1.291,p=0.002;直径标准OR=1.147,CI=1.040-1.265,p=0.006。
- 结节体积较小与显著结节生长相关:体积标准OR=0.870,CI=0.806-0.940,p<0.001;直径标准OR=0.912,CI=0.850-0.978,p=0.010。
- 4个原发结节诊断为甲状腺癌(0.5%),活检恶性率为1.4%(n=4)。
关键数值与推荐
- 直径标准:两个直径增加20%或2 mm视为显著生长。
- 体积标准:体积增加50%视为显著生长,体积按椭球公式计算。
- 指南建议:若发生显著结节生长,应重新评估细胞学。
临床怎么用
- 对超声和/或细胞学良性甲状腺结节进行长期随访时,可采用灵活的长期随访方案。
- 体积标准较直径标准更敏感地检出结节生长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The incidence of asymptomatic thyroid nodules has risen enormously, with > 90% being benign. Despite limited long-term data, significant nodule growth (SNG) is common. Guidelines recommend cytology reevaluation if SNG occurs. Our study aimed to identify the rate and factors associated with SNG, compare diameter and volume-based assessments, and examine the association between SNG and malignancy risk over the long term (10 years). Methods: The retrospective cohort study, conducted at Ankara University, School of Medicine, Department of Endocrinology and Metabolism, included 732 nodules from 376 euthyroid patients, all monitored over a 10-year period by the same experienced sonographer, with evaluations at baseline, 5th and 10th years. The nodules were cytologically benign and/or sonographically in the low-to-intermediate risk category. Size changes at the 5th and 10th years were considered significant if there was a 20% or 2 mm increment in two diameters according to diameter-based criterion (DBC) or 50% increment in volume-based criterion (VBC) designed by the ellipsoid formula. Generalized linear mixed-effects models were used to account for the clustered data structure and analyze factors affecting nodule growth. Nodule growth was the dependent variable, while sex, age at diagnosis, initial TSH level, total nodule count, nodule volume, echogenicity, and localization were independent variables. Results: At the 5th and 10th years, SNG frequencies were higher when calculated using VBC [27.7% (n = 203) and 44% (n = 321), respectively] compared with DBC [19.1% (n = 140) and 35% (n = 256), respectively], with the differences being statistically significant (McNemar test, p < 0.01). Factors associated with SNG included being younger than 45 years of age (VBC OR = 1.704, CI = 1.227-2.366, p = 0.002; DBC OR = 1.913, CI = 1.379-2.656, p < 0.001), having higher number of nodules (VBC: OR = 1.171, CI = 1.061-1.291, p = 0.002; DBC: OR = 1.147, CI = 1.040-1.265, p = 0.006), and having smaller nodule volume (VBC: OR = 0.870, CI = 0.806-0.940, p < 0.001; DBC: OR = 0.912, CI = 0.850-0.978, p = 0.010). Thyroid cancer was diagnosed in four original nodules (0.5%), whereas the malignancy rate in biopsies performed was 1.4% (n = 4). Conclusions: In long-term follow-ups of sonographically and/or cytologically benign thyroid nodules, SNG is not rare. Growth is more likely in younger patients, those with higher number of nodules and smaller nodules. In the follow-up of nodule size, VBCs yield augmented results compared with DBCs. However, malignancy is quite rare in growing nodules. Therefore, adopting flexible long-term follow-up protocols appears to be practical for benign nodular thyroid disease.
引用
- Erdoğan MF, Bahçecioğlu AB, Avcı Merdin F, et al. Changes in the Volume and Diameter of Benign Thyroid Nodules: A 10-Year Follow-Up Study. Thyroid. 2024. PMID: 39692610. doi:10.1089/thy.2024.0405
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。